Early HER2+ Breast Cancer
EP. 1: A 52-Year-Old Woman With HER2-Positive Breast Cancer
May 22nd 2019
EP. 2: Decision Factors for Choosing Early HER2-Positive Therapy
May 22nd 2019
EP. 3: The APHINITY Trial Regimen Efficacy & Toxicity Profile
May 22nd 2019
EP. 4: The Future of Early HER2-Positive Management
May 22nd 2019
